Related Experiment Video
Updated: Oct 21, 2025

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
Published on: April 16, 2021
SAMHD1 in cancer: curse or cure?
Kerstin Schott1, Catharina Majer1, Alla Bulashevska1
1Host-Pathogen Interactions, Paul-Ehrlich-Institut, Langen, Germany.
Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) plays a dual role in cancer, acting as a tumor suppressor but also potentially driving cancer development. Its functions impact chemotherapy sensitivity and DNA repair.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Sterile alpha motif and HD domain-containing protein 1 (SAMHD1) is a key enzyme regulating deoxynucleotide pools.
- SAMHD1 is increasingly recognized for its multifaceted roles beyond its enzymatic activity.
- Recent studies highlight SAMHD1's involvement in cancer development and progression.
Purpose of the Study:
- To review the role of SAMHD1 mutations in various cancer types.
- To discuss the dysregulation of SAMHD1 expression in cancer.
- To explore the functional consequences of SAMHD1 dysregulation in tumorigenesis and chemotherapy sensitivity.
Main Methods:
- Literature review of SAMHD1 in cancer research.
- Analysis of reported SAMHD1 mutations across different cancer types.
- Discussion of SAMHD1's enzymatic and non-enzymatic functions relevant to cancer.
Main Results:
- SAMHD1 mutations are found in diverse cancers, suggesting a role in tumor suppression.
- SAMHD1 dysregulation can influence tumor development and promote a mutator phenotype.
- SAMHD1 impacts chemotherapy sensitivity and innate immune responses.
Conclusions:
- SAMHD1 is a critical player at the intersection of DNA metabolism, immune response, and cancer.
- Understanding SAMHD1's complex roles is crucial for developing targeted cancer therapies.
- Further research into SAMHD1 mechanisms can elucidate its contribution to cancer development.
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

